Showing results (621-630 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|July 8, 2000
Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecinX W Zhang, C Qing, B Xu
Anti-Cancer Drugs|July 8, 2000
Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidinesJ A Hadfield, V H Pavlidis, P J Perry, et al.
Anti-Cancer Drugs|July 8, 2000
Medical care consumption in a phase III trial comparing irinotecan with infusional 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer after 5-FU failureC Schmitt, G Blijham, B Jolain, et al.
Anti-Cancer Drugs|December 29, 2000
Irinotecan-associated pulmonary toxicityY Madarnas, P Webster, A M Shorter, et al.
Anti-Cancer Drugs|December 29, 2000
Synthesis and antitumor activity of cyclotriphosphazene-(diamine)platinum(II) conjugatesH Baek, Y Cho, C O Lee, et al.
Anti-Cancer Drugs|December 29, 2000
Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigsK Watanabe, A Hess, O Michel, et al.
Anti-Cancer Drugs|December 29, 2000
Topoisomerase I inhibitor (camptothecin)-induced apoptosis in human gastric cancer cells and the role of wild-type p53 in the enhancement of its cytotoxicityZ W Zhang, S E Patchett, M J Farthing
Anti-Cancer Drugs|November 15, 2001
Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cellsT Funato, K Kozawa, M Kaku, et al.
Anti-Cancer Drugs|January 6, 2001
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administrationM M Malingré, J H Schellens, O van Tellingen, et al.
Anti-Cancer Drugs|November 18, 2000
Gastric carcinoma detected by cervical cytologyR Franchi, A Signaroldi, P Croce, et al.
Pageof 464